Perimeter Capital Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2014
Q4 | – | Sell |
-8,709
| Closed | -$255K | – | 17 |
|
2014
Q3 | $255K | Sell |
8,709
-32,632
| -79% | -$955K | 0.43% | 58 |
|
2014
Q2 | $1.61M | Buy |
41,341
+4,055
| +11% | +$158K | 0.82% | 28 |
|
2014
Q1 | $1.57M | Sell |
37,286
-6,332
| -15% | -$266K | 0.78% | 39 |
|
2013
Q4 | $1.43M | Buy |
43,618
+424
| +1% | +$13.9K | 0.7% | 54 |
|
2013
Q3 | $1.17M | Buy |
+43,194
| New | +$1.17M | 0.22% | 149 |
|